Skip to main content
Robert Den, MD, Radiation Oncology, Philadelphia, PA, Thomas Jefferson University Hospital

RobertB.DenMD

Radiation Oncology Philadelphia, PA

Thomas Jefferson University Radiation Oncology

Dr. Den is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Den's full profile

Already have an account?

Education & Training

  • Sidney Kimmel Medical College at Thomas Jefferson University/TJUH
    Sidney Kimmel Medical College at Thomas Jefferson University/TJUHResidency, Radiation Oncology, 2007 - 2011
  • Massachusetts General Hospital
    Massachusetts General HospitalResidency, Internal Medicine, 2006 - 2007
  • Harvard Medical School
    Harvard Medical SchoolClass of 2007

Certifications & Licensure

  • PA State Medical License
    PA State Medical License 2007 - 2024
  • NJ State Medical License
    NJ State Medical License 2017 - 2023
  • American Board of Radiology Radiation Oncology

Awards, Honors, & Recognition

  • CMS Meaningful Use Stage 1 Certification Allscripts Enterprise EHR, Allscripts, 2013

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Tumor Cell Heterogeneity and Resistance; Report from the 2018 Coffey‐Holden Prostate Cancer Academy Meeting  
    Thomas A Hope, Kenneth J Pienta, Fatima Karzai, Simpa S Salami, Robert B Den, The Prostate
  • Comparison Between Adjuvant and Early-Salvage Postprostatectomy Radiotherapy for Prostate Cancer with Adverse Pathological Features  
    Rahul D. Tendulkar, Kevin L. Stephans, Stanley L. Liauw, Robert B. Den, Shre Agrawal, Mitchel S. Anscher, Jason A. Efstathiou, Thomas M. Pisansky, Jason W. Hearn, Jef ..., JAMA

Press Mentions

  • Alpha Tau Announces Alpha DaRT™ Treatment of First Two Patients in Its Pivotal Multicenter Recurrent Skin Cancer (ReSTART) Trial
    Alpha Tau Announces Alpha DaRT™ Treatment of First Two Patients in Its Pivotal Multicenter Recurrent Skin Cancer (ReSTART) TrialMarch 8th, 2023
  • Decipher Biosciences Announces Publication of a Prospective Clinical Study Demonstrating That the Use of Decipher Prostate RP Guides Post-Operative Management Decisions and Improves Patient Outcomes
    Decipher Biosciences Announces Publication of a Prospective Clinical Study Demonstrating That the Use of Decipher Prostate RP Guides Post-Operative Management Decisions and Improves Patient OutcomesDecember 16th, 2019
  • Alpha Tau Medical Appoints Jefferson University Radiation Oncologist Robert Den as Chief Medical Officer
    Alpha Tau Medical Appoints Jefferson University Radiation Oncologist Robert Den as Chief Medical OfficerSeptember 4th, 2019
  • Join now to see all

Professional Memberships

Hospital Affiliations